Pemetrexed and cisplatin combination with concurrent whole brain radiotherapy in patients with brain metastases of lung adenocarcinoma: a single-arm phase II clinical trial

Impact of non-small cell lung cancer histology on survival predicted from the graded prognostic assessment for patients with brain metastases

(2012) Susan Guo et al.   LUNG CANCER

Upfront association of carboplatin plus pemetrexed in patients with brain metastases of lung adenocarcinoma

(2012) O. Bailon et al.   NEURO-ONCOLOGY

Pemetrexed and cisplatin as first-line chemotherapy for advanced non-small-cell lung cancer (NSCLC) with asymptomatic inoperable brain metastases: a multicenter phase II trial (GFPC 07-01)

(2011) F. Barlesi et al.   ANNALS OF ONCOLOGY

Brain Metastases as the Primary Site of Relapse in Two Randomized Phase III Pemetrexed Trials in Advanced Non–Small-Cell Lung Cancer

(2011) Waldo Ortuzar et al.   Clinical Lung Cancer

Phase I Trial of Radiation With Concurrent and Consolidation Pemetrexed and Cisplatin in Patients With Unresectable Stage IIIA/B Non–Small-Cell Lung Cancer

(2010) Anthony Brade et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Diagnosis-Specific Prognostic Factors, Indexes, and Treatment Outcomes for Patients With Newly Diagnosed Brain Metastases: A Multi-Institutional Analysis of 4,259 Patients

(2009) Paul W. Sperduto et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Activity of Pemetrexed on brain metastases from Non-Small Cell Lung Cancer

(2009) Alessandra Bearz et al.   LUNG CANCER

Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer

(2008) Giorgio Vittorio Scagliotti et al.   JOURNAL OF CLINICAL ONCOLOGY

Treatment of brain metastasis from non-small cell lung cancer with whole brain radiotherapy and Gefitinib in a Chinese population

(2008) Shenglin Ma et al.   LUNG CANCER